1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (617) 726-4899
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Low bone mineral density in hormone-naïve men with prostate carcinoma
Article first published online: 13 JUN 2001
DOI: 10.1002/1097-0142(20010615)91:12<2238::AID-CNCR1254>3.0.CO;2-2
Copyright © 2001 American Cancer Society
Additional Information
How to Cite
Smith, M. R., McGovern, F. J., Fallon, M. A., Schoenfeld, D., Kantoff, P. W. and Finkelstein, J. S. (2001), Low bone mineral density in hormone-naïve men with prostate carcinoma. Cancer, 91: 2238–2245. doi: 10.1002/1097-0142(20010615)91:12<2238::AID-CNCR1254>3.0.CO;2-2
Publication History
- Issue published online: 13 JUN 2001
- Article first published online: 13 JUN 2001
- Manuscript Accepted: 12 MAR 2001
- Manuscript Revised: 6 MAR 2001
- Manuscript Received: 30 NOV 2000
Funded by
- National Institutes of Health. Grant Numbers: RR-1066, K24 DK02759
- CaP CURE
- Novartis Oncology
- Doris Duke Charitable Foundation
- Abstract
- Article
- References
- Cited By
Keywords:
- prostatic neoplasms;
- bone;
- osteoporosis;
- androgen-deprivation therapy
In this study, the authors demonstrate that many men with prostate carcinoma and no history of androgen-deprivation therapy have low bone mineral density. Risk factors for osteoporosis, including low dietary calcium intake, hypogonadism, and hypovitaminosis D, are common.
Abstract
BACKGROUND
The objective of this study was to determine the prevalence of low bone mineral density in men with prostate carcinoma and no history of androgen-deprivation therapy.
METHODS
The authors conducted a cross-sectional study in 41 hormone-naïve men with locally advanced, lymph node positive, or recurrent prostate carcinoma and no radiographic evidence of bone metastases. Bone mineral density of the total hip, posterior-anterior (PA) lumbar spine, and lateral lumbar spine was determined by dual-energy X-ray absorptiometry (DXA) using a densitometer. Trabecular bone mineral density of the lumbar spine was determined by quantitative computed tomography (QCT). Bone mineral density results were expressed in standard deviation units relative to young adult men (T score) and relative to age-matched men (Z score).
RESULTS
Fourteen of 41 men (34%; 95% confidence interval [95% CI], 20–51%) had T scores < −1.0 at one or more skeletal sites by DXA, 12 of 41 men (29%; 95% CI, 16–42%) had T scores between −1.0 and −2.5, and 2 of 41 men (5%; 95% CI, 1–17%) had T scores < −2.5. Thirty-nine of 41 men (95%; 95% CI, 83–99%) had T scores < −1.0 by QCT, 13 of 41 men (31%; 95% CI 18–48%) had T scores between −1.0 and −2.5, and 26 of 41 men (63%; 95% CI, 47–78%) had T scores < −2.5. T scores for trabecular bone mineral density of the lumbar spine were significantly lower than T scores for either the total hip (P < 0.001) or the PA lumbar spine (P < 0.001). The mean Z score for trabecular bone mineral density of the lumbar spine was −0.7 ± 0.9. Hypogonadism, hypovitaminosis D, and dietary calcium intakes below the Recommended Daily Allowance were observed in 20%, and 17%, and 59% of study participants, respectively.
CONCLUSIONS
Many hormone-naïve men with prostate carcinoma have low bone mineral density. QCT is a more sensitive method than DXA for diagnosing low bone mineral density in this patient population. Trabecular bone mineral density is lower than expected for age and risk factors for osteoporosis are common. Cancer 2001;91:2238–45. © 2001 American Cancer Society.